IP Library Granted Patent US 9,260,695
Granted Patent B2
US 9,260,695 · App. 14/052,878 · Granted Feb 16, 2016

Process for cell culturing by continuous perfusion

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,260,695
App. No.
14/052,878
Granted
Feb 16, 2016
Kind
B2
Abstract

The invention relates to a process for the culturing of cells by continuous perfusion culturing of a cell culture comprising cell culture medium and cells, wherein cell culture medium is added to the cell culture, the cell culture is circulated over a filter module comprising hollow fibers resulting in an outflow of liquid having a lower cell density than the cell culture and the flow within the filter module is an alternating tangential flow. Preferably, culture medium is added at a particular perfusion rate and/or biomass is removed form the culture at least once. The method is especially suitable for the culturing of aggregating cells. The invention also relates to such a process wherein a biological substance, preferably an antibody, is produced by the cells, which biological substance may be further purified in downstream processing.

Claims (24)

1. A method for limiting cell aggregation during cell culture to a level wherein no more than 5% of the animal cells in suspension in the culture comprise aggregates of at least 5 cells, comprising:

culturing of a cell culture comprising cell culture medium and animal cells that easily or inherently form aggregates during culturing, wherein the culturing comprises:

(a) circulating the cell culture through a filter module comprising hollow fibers, in an alternating tangential flow resulting in an outflow of cell culture liquid through the pores of the filter module having a lower animal cell density per ml than the cell culture prior to circulating through the filter module; and

(b) adding cell culture medium to the cell culture, and

wherein no more than 5% of the animal cells in the culture form aggregates in suspension of at least 5 cells during the culturing, and wherein the culturing is continued until animal cells are present in the cell culture at a density of at least 80×10 6 viable animal cells/ml.

2. The method of claim 1 , wherein biomass is removed at least once from the cell culture and additional cell culture medium is added to the cell culture to compensate for the biomass removal.

3. The method of claim 2 , wherein the biomass removal is started just before or just after the animal cell density has reached a steady state.

4. The method of claim 2 , wherein the volume of biomass removed is between 2% and 40% of the total volume of the cell culture per day.

5. The method of claim 1 , wherein a first pump circulates the cell culture within the filter module comprising hollow fibers and a second pump removes the liquid having a lower cell density than the cell culture prior to circulating through the filter module.

6. The method of claim 1 , wherein the animal cells are cultured to a cell viability of at least 90%.

7. The method of claim 1 , wherein no more than 4% of the animal cells in the culture form aggregates in suspension of at least 5 cells during the culturing.

8. The method of claim 1 , wherein the cells are mammalian cells.

9. The method of claim 8 , wherein the mammalian cells are human cells.

10. The method of claim 1 , wherein the cells produce a biological substance.

11. The method of claim 10 , wherein the biological substance is a protein or a polynucleotide.

12. The method of claim 10 , wherein the biological substance is further purified from the cell culture in downstream processing.

13. The method of claim 3 , wherein the cells are mammalian cells.

14. The method of claim 13 , wherein the mammalian cells are human cells.

15. The method of claim 13 , wherein the cells produce a biological substance.

16. The method of claim 15 , wherein the biological substance is a protein or a polynucleotide.

17. The method of claim 15 , wherein the biological substance is further purified from the cell culture in downstream processing.

18. The method of claim 14 , wherein the cells produce a biological substance.

19. The method of claim 18 , wherein the biological substance is a protein or a polynucleotide.

20. The method of claim 18 , wherein the biological substance is further purified from the cell culture in downstream processing.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 033564 FRAME: 0887. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 25, 2016
From: DSM IP ASSETS B.V.
To: DPX HOLDINGS B.V.
Reel/Frame 037583/0908 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2014
From: DSM IP ASSETS B.V.
To: DPX HOLDINGS B.V.
Reel/Frame 033564/0887 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2013
From: CROWLEY, JOHN; WUBBEN, MAIKE; COCO MARTIN, JOSE MANUEL
To: DSM IP ASSETS B.V.
Reel/Frame 031419/0758 →